News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires5d agobullish
UBS Adjusts Price Target on Vertex Pharmaceuticals to $640 From $615, Maintains Buy RatingMT Newswires5d agobullish
RBC Raises Price Target on Vertex Pharmaceuticals to $600 From $576, Keeps Outperform RatingInvestor's Business Daily6d agobullish
Vertex Continues Its Buy-Zone Run After Hiking 2026 Sales GuidanceInvestor's Business Daily47d agobullish
The Surprise That Sent Vertex - And Its Chief Rival - SoaringGuruFocus.com96d agobullish
Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) Earnings Call Highlights: Revenue Surges 12% to $3. ...Motley Fool118d agobullish
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?The Wall Street Journal124d agobullish
🔎 Under the Radar: Vera Stock Jumps as Kidney-Disease Drug Approved by FDASimply Wall St.128d agobullish
Vertex Pharmaceuticals (VRTX) Wins FDA Approval To Treat Two Year Olds With CASGEVY